Boosting Trial Success Through Blinded Data Analytics: What Can We Learn From CNS? Date Published: Aug 17, 2020 Article This Journal of Clinical Studies article discusses the potential problems with subjective CNS data. Learn why the below causes data issues that can undermine a study: Traditional outcome scoring Paper-based assessments Manual calculations Insufficient rater training & monitoring Readers will learn how Signant solves these issues with advanced solutions, such as electronic Clinician Outcome Assessments (eCOA) and Blinded Data Analytics to services like Rater Training. To obtain reliable endpoints, sponsors should proactively address potential data problems. Download Now Share: LinkedInTweet Recommended Resources Article Conversation with Bill Byrom & Mariana Fontana: Measuring Aspects of Health in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Marianna Fontana, Professor... Download Now Article Conversation with Bill Byrom & Julian Gillmore: Increasing the Usefulness of COAs in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Julian Gillmore, Professor... Download Now Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now